Senior Scientist for scouting early-stage technologies and innovation

Are you passionate about pushing the boundaries of drug discovery? Do you have a keen eye for novel biological, pharmaceutical, and technological innovations and the skills to evaluate their potential? Can you thrive in a dynamic environment, where collaboration, problem-solving, and cutting-edge science are at the core? If so, we have a unique career opportunity where you contribute to the Discovery & Partnership (D&P) pipeline at Gubra.

Why join Gubra?

[xxxxx]is an ambitious and science-driven biotech company with a strong R&D pipeline focusing on metabolic, fibrotic, and inflammatory diseases. Our AI/ML-powered peptide drug discovery platform, streaMLine, enables rapid development from target identification to preclinical candidate selection. We are dedicated to innovation, efficiency, and pushing scientific boundaries to discover novel therapeutics. 

Your Role as a Senior scientist

We are seeking a Senior Scientist to join our cross-disciplinary team in Gubra’s Cambridge office. You will be a part of projects in our D&P area supporting the work with the new innovation strategy. You will proactively identify and scientifically evaluate early-stage technologies and targets that complement and enhance our D&P efforts.

Your primary areas of responsibility will be:

• Scout and evaluate early-stage targets and technologies relevant for drug discovery and M&A.
• Conduct detailed scientific assessments to determine the potential fit of emerging technologies.
• Support drug and target discovery efforts.
• Attend and actively engage in relevant conferences and scientific community.
• Actively connect and feed knowledge into the Gubra’s R&D organization
• Contribute to our innovation agenda
• Stay updated on industry trends, market dynamics, and competitive landscape to identify potential threats and opportunities

We are looking for a person with:

• A relevant PhD in life sciences or a related field
• Demonstrated experience in drug discovery, with a robust scientific foundation.
• Relevant expertise to effectively evaluate diverse scientific approaches and opportunities.
• Experience with Peptide-based drug discovery/target discovery is a plus
• Excellent communication skills, with the ability to represent the organization at industry events and conferences.
• Strong academic and industry networks are a plus.
• A proactive and entrepreneurial mindset and the capability of building stakeholder relationships
• A well-structured, analytical, hands-on approach.
• Excitement to work in a small team and ever-changing environment.

Please apply no later than 21st of May 2025 by uploading your motivated cover letter, resumé, and relevant diplomas on our website. Please apply as soon as possible and note that applications will be reviewed on an ongoing basis. If you have questions about the position, please contact Head of [xxxxx]US, Frederik Friis-Hansen at [xxxxx] Gubra

[xxxxx]is an ambitious contract research organisation (CRO) and biotech company striving for excellence at all levels. We insist on doing things efficiently – and often differently - to reach the results we aim for. Our vision is to become leaders in the fight for a more sustainable and healthier world. We do that by facilitating the discovery of new medicine, and by acting and inspiring others to fight the ongoing climate and biodiversity crises.

Gubra’s activities are focused on the early stages of drug development and are organised in two highly synergistic business areas: CRO Services and Discovery & Partnerships (D&P). We generate our revenue by performing research for life science companies as well as by partnering projects from our discovery and development pipeline.

Our therapeutic focus is within metabolic and fibrotic diseases, and we specialize in in vivo pharmacology, ex vivo assays, drug profiling, histology, stereology and whole brain and organ imaging. In addition, we offer a full palette of advanced transcriptomics. Our ML/AI-driven peptide drug discovery platform streaMLine enables us to rapidly develop a peptide hit into a non-clinical candidate ready for development. Through a constant focus on high quality, scientific excellence, speed, and solid teamwork we have established ourselves as a highly professional and competent partner in the market.

People are our greatest asset, and our team consists of +270 employees located in Hørsholm, Denmark and Cambridge, USA. The mix of people from different cultures and educational backgrounds combined with our entrepreneurial mindset have greatly impacted our working environment, which is characterized by entrepreneurial drive, scientific curiosity, and teamwork – we join forces!